The FDA Puts a Hold on the Medication Avandia
The FDA (Food and Drug Administration) has put a hold on the clinical studies being done of the prescription medication Avandia not allowing new patients to enroll in the studies.
The clinical studies began in 2007 and even at that time, the FDA was skeptical about the drug. They were concerned about potential heart problems for diabetics who took the drug.
The maker GlaxoSmithKline also had their own concerns about diabetics developing heart problems or for those who already had heart problems an increased concern that those diabetics heart conditions could in fact worsen on the medication.
The study was originally designed to see if Avandia would have a greater risk on diabetics as similar medications or the same risks. At this point, it has proved to have an increased risk.
At this time, the FDA has suspended any new diabetics from being a part of the clinical trials and taking the medication until they can further determine the possible causes for the risk in heart conditions associated with the medication and try to find a way to prevent it.